Pharmas worrying whether to unveil successful outcomes in this political situation

“Should we, or shouldn’t we…”

Pharmaceutical companies have a concern lately. It is whether they should announce successful outcomes, which were created by R&D with great ef forts and challenges to the global market, in the market right now or postpone it for a while.

It is true these concerns are created by the people’s perspective lessened by the Hanmi Pharm’s delayed announcement incident ...